PORTAGE BIOTECH
Portage is engaged in researching and developing pharmaceutical and biotech products through to clinical "proof of concept" with an initial focus on unmet clinical needs. Following proof of concept, Portage will look to sell or license the products to large pharmaceutical companies for further development and commercialization. Portage is seeking discovery and co-development partners in areas such as cancer, infectious disease, neurology and psychiatry developing novel targeted therapies, stem cell therapy and even older marketed products that have been found to have novel patentable characteristics that bring new value to patients.
PORTAGE BIOTECH
Industry:
Biotechnology Pharmaceutical
Founded:
1973-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.portagebiotech.com
Total Employee:
1+
Status:
Active
Contact:
(416) 929-1806
Total Funding:
50.64 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Google Maps Global Site Tag Mobile Non Scaleable Content
Similar Organizations
Aprecia Pharmaceuticals
Aprecia Pharmaceuticals develops precision drug delivery systems and products.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Ian B. Walters CEO @ Portage Biotech
CEO
Greg Bailey Chairman @ Portage Biotech
Chairman
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-07-06 | Tarus Therapeutics | Tarus Therapeutics acquired by Portage Biotech | 21 M USD |
| 2018-08-14 | SalvaRx Ltd. | SalvaRx Ltd. acquired by Portage Biotech | 71.7 M USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-05-11 | Stimunity | Portage Biotech investment in Seed Round - Stimunity | 900 K EUR |
| 2019-03-25 | Stimunity | Portage Biotech investment in Seed Round - Stimunity | 600 K EUR |
| 2018-03-08 | iOx Therapeutics Ltd. | Portage Biotech investment in Convertible Note - iOx Therapeutics Ltd. | 950 K USD |
| 2018-03-01 | Stimunity | Portage Biotech investment in Seed Round - Stimunity | 2 M EUR |
Official Site Inspections
http://www.portagebiotech.com Semrush global rank: 4.43 M Semrush visits lastest month: 2.18 K
- Host name: 133.191.196.104.bc.googleusercontent.com
- IP address: 104.196.191.133
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Portage Biotech"
about us - Portage Biotech
Alexander help find SalvaRx Limited, a cancer immunotherapy-focused investment company that was later merged into Portage Biotech. Prior to joining Mediqventures, Alexander was an …See details»
Investor Relations | Portage Biotech
Encouraging Safety Profile Supports Progression Toward First Dual-Administration of Selective A2A and A2B Antagonists in Patients DOVER, Del. , March 12, 2025 (GLOBE NEWSWIRE) -- …See details»
Portage Biotech - Crunchbase Company Profile
Portage Biotech is a pharmaceutical company that identifies and develops best-in-class or first-in-class early-to-mid stage products.See details»
Portage Biotech Inc. | The Canadian Securities Exchange (CSE)
Oct 28, 2013 Portage is a unique entity in the world of biotechnology, enabling research and development to produce more clinical programs and maximize potential returns by eliminating …See details»
join our team - Portage Biotech
If you are interested in joining our team to develop novel cancer therapies to improve patient lives, please contact us at careers@portagebiotech.com. Portage Biotech Inc. Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, …See details»
Portage Biotech Inc - LinkedIn
Portage Biotech Inc | 830 followers on LinkedIn. Accelerating promising medicines that revolutionize treatment for patients with cancer | Portage Biotech is clinical stage …See details»
Portage Biotech Inc. (PRTG) - Yahoo Finance Canada
See the company profile for Portage Biotech Inc. (PRTG) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Portage Biotech - 2025 Company Profile & Funding - Tracxn
Mar 12, 2025 Portage Biotech - Therapeutics based on Cell Permeable Peptide Platform. Public Company. Raised funding over 5 rounds from 1 investor.See details»
Portage Biotech Company Profile - Office Locations, Competitors …
Apr 12, 2021 See insights on Portage Biotech including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Portage Biotech Inc - Work in biotech
Portage Biotech Inc. is a clinical-stage immuno-oncology company dedicated to developing innovative therapies for cancer treatment. Their focus is on advancing first-in-class treatments …See details»
Portage Biotech Inc - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Portage Biotech Inc of Toronto, ON. Get the latest business insights from Dun & Bradstreet.See details»
News Release Details - ir.portagebiotech.com
For more information, visit www.portagebiotech.com. Forward-Looking Statements All statements in this news release, other than statements of historical facts, including without limitation, …See details»
our pipeline - Portage Biotech
Additional Programs in Development . Portage’s pipeline also includes antibodies, small molecules and protein therapeutics delivered by novel intratumoral formulations (PORT-1), …See details»
Portage Biotech Inc Ord (PRTG-Q) Profile - The Globe and Mail
See the company profile for Portage Biotech Inc Ord (PRTG-Q) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
Portage Biotech Announces $6.0 Million Registered Direct Offering
WESTPORT, Conn., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies …See details»
Portage Biotech Announces Plans to Expand its Evaluation of …
Apr 12, 2024 -Adenosine clinical development pausedWESTPORT, Conn., April 12, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno …See details»
Portage Biotech Reports Promising Preclinical Results in ... - Nasdaq
3 days ago --Portage Biotech Inc., a clinical-stage immuno-oncology company with a portfolio of innovative therapeutics, presented new preclinical data for PORT-7, a selective Adenosine …See details»
PORT-4 – Nanolipogel Formulations - Portage Biotech
Portage Biotech Inc. Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, British Virgin Islands, VG1110 203.221.7378 media@portagebiotech.comSee details»
Portage Biotech Reports Promising Preclinical Results in
3 days ago For more information, visit www.portagebiotech.com. Forward-Looking Statements All statements in this news release, other than statements of historical facts, including without …See details»
PORTAGE BIOTECH INC.
Mar 31, 2022 visit www.portagebiotech.com, follow us on Twitter at @PortageBiotech or find us on LinkedIn at Portage Biotech Inc. Forward-Looking Statements This news release contains …See details»